7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with dinoprostone in 13 studies
| Studies (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Trials (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Recent Studies (post-2010) (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 39 | 15 | 14 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayatepek, E; Nützenadel, W; Seyberth, HW | 1 |
| Schweer, H; Seyberth, HW; Watzer, B | 1 |
| Hoffmann, GF; Linderkamp, O; Mayatepek, E; Meyburg, J; Seyberth, HW | 1 |
| Frölich, JC; Stichtenoth, DO; Wagner, B | 1 |
| Girschick, HJ; Huppertz, HI; Seyberth, HW | 1 |
| Bernhard, M; Hoch, B | 1 |
| Byrne, LM; Csiki, I; Johnson, DH; Morrow, JD; Murphey, LJ; Oates, JA; Sanchez, SC; Williams, MK | 1 |
| Boyle, JO; Dannenberg, AJ; Duffield-Lillico, AJ; Gross, ND; Morrow, JD; Moskowitz, CS; Subbaramaiah, K; Williams, MK | 1 |
| Carbone, DP; Csiki, I; Dang, T; Johnson, DH; Morrow, JD; Oates, J; Sandler, A; Shyr, Y; Williams, MK | 1 |
| Frölich, JC; Gutzki, FM; Marhauer, V; Stichtenoth, DO; Tsikas, D | 1 |
| Cohen, DA; Haack, M; Lee, E; Mullington, JM | 1 |
| Cai, Q; Chen, Z; Milne, G; Ness, RM; Shrubsole, MJ; Smalley, WE; Wen, W; Zheng, W | 1 |
| Fu, WZ; He, JW; Zhang, CQ; Zhang, Z; Zhang, ZL | 1 |
5 trial(s) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and dinoprostone
| Article | Year |
|---|---|
Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; Indomethacin; Meloxicam; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Therapeutic Equivalency; Thiazines; Thiazoles; Thromboxane B2 | 1997 |
Central apnoea and endogenous prostaglandins in neonates.
Topics: Apnea; Bradycardia; Chromatography, Gas; Data Interpretation, Statistical; Dinoprostone; Electrocardiography; Female; Heart Rate; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Mass Spectrometry; Oximetry; Oxygen; Plethysmography; Polysomnography; Prostaglandins; Time Factors | 2000 |
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inducing Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Celecoxib; Cohort Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Docetaxel; Endostatins; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Membrane Proteins; Middle Aged; Nausea; Neoplasm Recurrence, Local; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Sulfonamides; Survival Analysis; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A; Vomiting | 2005 |
Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Body Weight; Celecoxib; Creatinine; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Diuretics; Female; Furosemide; Humans; Indomethacin; Kidney; Potassium; Prostaglandins; Pyrazoles; Renin; Sodium; Sulfonamides; Thromboxane B2 | 2005 |
Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain.
Topics: Adult; Affect; Dinoprostone; Female; Humans; Linear Models; Male; Middle Aged; Pain Measurement; Pain Threshold; Polysomnography; Prostaglandins; Sleep; Sleep Deprivation; Wakefulness; Young Adult | 2009 |
8 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and dinoprostone
| Article | Year |
|---|---|
Effects of indomethacin in congenital chloride diarrhea.
Topics: 18-Hydroxycorticosterone; Aldosterone; Chlorine; Diarrhea; Dinoprost; Dinoprostone; Humans; Indomethacin; Infant; Male; Potassium Chloride; Prostaglandins; Renin; Sodium Chloride; Water-Electrolyte Balance | 1992 |
Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry.
Topics: 6-Ketoprostaglandin F1 alpha; Chromatography, Thin Layer; Dinoprostone; Gas Chromatography-Mass Spectrometry; Humans; Prostaglandins; Thromboxane B2 | 1994 |
Severe hyperchloriduria-hyperkaliuria: a new congenital renal tubular abnormality?
Topics: Bartter Syndrome; Calcium; Chlorides; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; Indomethacin; Infant; Potassium; Prostaglandins; Renal Tubular Transport, Inborn Errors; Syndrome | 1996 |
Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Dinoprostone; Follow-Up Studies; Gait; Humans; Hypophosphatasia; Infant; Kidney; Leg; Male; Pain; Prostaglandins | 1999 |
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Chromatography, Liquid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Health; Humans; Lung Neoplasms; Membrane Proteins; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2004 |
Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Dinoprostone; Female; Head and Neck Neoplasms; Humans; Logistic Models; Male; Mass Spectrometry; Middle Aged; Prostaglandins; Prostaglandins E; Smoking | 2005 |
Urinary prostaglandin E2 metabolite and risk for colorectal adenoma.
Topics: Adenoma; Adult; Aged; Biomarkers, Tumor; Case-Control Studies; Colorectal Neoplasms; Cyclooxygenase 2; Dinoprostone; Female; Humans; Male; Middle Aged; Prognosis; Prostaglandins | 2012 |
Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Topics: Adolescent; Adult; Age Factors; Amino Acid Sequence; China; Cohort Studies; Dinoprostone; DNA Mutational Analysis; Family Health; Female; Genetic Association Studies; Humans; Male; Molecular Sequence Data; Mutation; Organic Anion Transporters; Osteoarthropathy, Primary Hypertrophic; Pedigree; Prostaglandins; Protein Structure, Secondary; Sequence Alignment; Young Adult | 2013 |